Literature DB >> 12957728

PON1 activities and oxidative markers of LDL in patients with angiographically proven coronary artery disease.

Elif Azarsiz1, Meral Kayikcioglu, Serdar Payzin, Eser Yildirim Sözmen.   

Abstract

BACKGROUND: There is growing evidence that ox-LDL plays an important role during the atherosclerosis process and PON1 can significantly inhibit generation of lipid peroxidation during LDL oxidation and thus play a role in the in vivo protection by HDL against atherosclerosis.
METHODS: Twenty-four healthy volunteers and one-hundred and one patients were taken into study, sixty-eight patients had coronary artery disease which was confirmed by coronary angiography. Serum PON1, erythrocyte superoxide dismutase and catalase activities, oxidative markers of LDL were determined along with the routine biochemical parameters in all groups.
RESULTS: The indicators of oxidative stress were higher in the patients compared with the controls. No statistically significant difference in any of parameters were observed between the patients who had obstruction with different degrees except for erythrocyte TBARS [24.5 nM/g Hb in patients with one vessel disease (VD) (n=22), 29.6 nM/g Hb in patients with two VD (n=26) and 33.5 nM/g Hb in patients with three VD (n=20)]. Basal and stimulated diene levels were higher in patients who had more diseased vessels than those who had less.
CONCLUSION: The increase in erythrocyte TBARS and CRP levels with the severity of disease supports the reports that showed the inflammatory and oxidative nature of atherosclerosis. In the light of the fact that the well-known classical risk factors for atherosclerosis are closely associated with increased oxidative stress, we propose that the elevation in TBARS levels might be a more marked indicator for the degree of atherosclerosis than the insufficiency in antioxidant enzymes such as SOD and PON1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12957728     DOI: 10.1016/s0167-5273(02)00595-8

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

1.  Albuminuria, the High-Density Lipoprotein Proteome, and Coronary Artery Calcification in Type 1 Diabetes Mellitus.

Authors:  Baohai Shao; Leila R Zelnick; Jake Wimberger; Jonathan Himmelfarb; John Brunzell; W Sean Davidson; Janet K Snell-Bergeon; Karin E Bornfeldt; Ian H de Boer; Jay W Heinecke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-05-16       Impact factor: 8.311

2.  Evaluation of serum neopterin, high-sensitivity C-reactive protein and thiobarbituric acid reactive substances in Egyptian patients with acute coronary syndromes.

Authors:  M Ragab; H Hassan; T Zaytoun; W Refai; B Rocks; M Elsammak
Journal:  Exp Clin Cardiol       Date:  2005

3.  Longitudinal changes in PON1 enzymatic activities in Mexican-American mothers and children with different genotypes and haplotypes.

Authors:  Karen Huen; Kim Harley; Asa Bradman; Brenda Eskenazi; Nina Holland
Journal:  Toxicol Appl Pharmacol       Date:  2010-01-04       Impact factor: 4.219

Review 4.  Measurement of Reactive Oxygen Species, Reactive Nitrogen Species, and Redox-Dependent Signaling in the Cardiovascular System: A Scientific Statement From the American Heart Association.

Authors:  Kathy K Griendling; Rhian M Touyz; Jay L Zweier; Sergey Dikalov; William Chilian; Yeong-Renn Chen; David G Harrison; Aruni Bhatnagar
Journal:  Circ Res       Date:  2016-07-14       Impact factor: 17.367

Review 5.  Paraoxonase (PON)-1: a brief overview on genetics, structure, polymorphisms and clinical relevance.

Authors:  Nelusha Shunmoogam; Poobalan Naidoo; Robert Chilton
Journal:  Vasc Health Risk Manag       Date:  2018-06-18

6.  The role of cholesterol-enriched diet and paraoxonase 1 inhibition in atherosclerosis progression.

Authors:  Masoumeh Amani; Akbar Darbin; Masoud Pezeshkian; Abbas Afrasiabi; Naser Safaie; Ahmadreza Jodati; Masoud Darabi; Maghsod Shaaker; Zeinab Latifi; Amir Fattahi; Gholam-Hossein Farjah; Mohammad Nouri; Mohammad Hassan Khadem-Ansari
Journal:  J Cardiovasc Thorac Res       Date:  2017-08-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.